Zenas Biopharma Inc (ZBIO)

SG&A Expense Growth

-6.86%

Quarterly · Period ending:

ZBIO logo

ZBIO SG&A Expense Growth

Latest reported-6.86%
ZBIO Quarterly SG&A Growth (QoQ) (0.00% → -6.86%)
High-resolution chart · PNG

ZBIO sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zenas Biopharma Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-6.856%
8.421%
18.3184%
8.586%
-2.2473%
8.2766%
53.8235%
26.4461%
19.5013%
13.1163%
-13.1967%
25.9148%
6.713%
15.9739%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.